FDA

Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.

A panel of experts advising the Food and Drug Administration will weigh the safety and effectiveness of the COVID-19 vaccine from Pfizer and BioNTech in a daylong public meeting. The committee will vote on whether the FDA should authorize the vaccine for emergency use during the pandemic.